Editas Medicine (EDIT) Prices First IPO of 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Editas Medicine (EDIT) IPO Opens Flat
February 3, 2016 11:03 AM ESTToday's IPO for Editas Medicine (NASDAQ: EDIT) opened for trading at $16.10 after pricing 5,900,000 shares at $16 per share, the low end of the expected $16-$18 range.
The offering was led by Morgan Stanley, JP Morgan, Cowen and JMP Securities.
Editas Medicine is a... More



